Solid Biosciences Inc. Capital Expenditures Incurred but Not yet Paid
Solid Biosciences Inc. (SLDB) reported Capital Expenditures Incurred but Not yet Paid of $285.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-08-06
- Solid Biosciences Inc. capital expenditures incurred but not yet paid for the quarter ending 2026-06-30 was $260.00K.
- Solid Biosciences Inc. capital expenditures incurred but not yet paid for the quarter ending 2026-03-31 was $25.00K, a 68.75% decline year-over-year.
- Solid Biosciences Inc. capital expenditures incurred but not yet paid for the quarter ending 2025-12-31 was -$283.00K.
- Solid Biosciences Inc. capital expenditures incurred but not yet paid for the quarter ending 2025-09-30 was $329.00K, a 1956.25% increase year-over-year.
- Solid Biosciences Inc. capital expenditures incurred but not yet paid for fiscal 2025 was $46.00K.
- Solid Biosciences Inc. capital expenditures incurred but not yet paid for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- Solid Biosciences Inc. capital expenditures incurred but not yet paid for fiscal 2023 was $76.00K, a 85.58% decline from fiscal 2022.
- Solid Biosciences Inc. capital expenditures incurred but not yet paid for fiscal 2022 was $527.00K, a 406.73% increase from fiscal 2021.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2026-06-30 | $260.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $285.00K 10-Q · filed 2026-08-06 | $2.00K derived: sum of 3 quarters · filed 2026-08-06 | $331.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $25.00K 10-Q · filed 2026-05-12 | -$258.00K derived: sum of 2 quarters · filed 2026-05-12 | $71.00K derived: sum of 3 quarters · filed 2026-05-12 | -$9.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$283.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $46.00K derived: sum of 2 quarters · filed 2026-03-19 | -$34.00K derived: sum of 3 quarters · filed 2026-08-06 | $46.00K 10-K · filed 2026-03-19 |
| 2025-09-30 | $329.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $249.00K derived: sum of 2 quarters · filed 2026-08-06 | $329.00K 10-Q · filed 2025-11-03 | $293.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$80.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $0.00 10-Q · filed 2026-08-06 | -$36.00K derived: sum of 3 quarters · filed 2026-08-06 | -$20.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $80.00K 10-Q · filed 2026-05-12 | $44.00K derived: sum of 2 quarters · filed 2026-05-12 | $60.00K derived: sum of 3 quarters · filed 2026-05-12 | $60.00K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | -$36.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | -$20.00K derived: sum of 2 quarters · filed 2026-03-19 | -$20.00K derived: sum of 3 quarters · filed 2026-03-19 | $0.00 10-K · filed 2026-03-19 |
| 2024-09-30 | $16.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $16.00K derived: sum of 2 quarters · filed 2025-11-03 | $36.00K 10-Q · filed 2025-11-03 | $112.00K derived: sum of 4 quarters · filed 2025-11-03 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $20.00K 10-Q · filed 2025-08-12 | $96.00K derived: sum of 3 quarters · filed 2025-08-12 | -$45.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $20.00K 10-Q · filed 2025-05-15 | $96.00K derived: sum of 2 quarters · filed 2025-05-15 | -$45.00K derived: sum of 3 quarters · filed 2025-05-15 | |
| 2023-12-31 | $76.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | -$65.00K derived: sum of 2 quarters · filed 2025-03-06 | $76.00K 10-K · filed 2025-03-06 | |
| 2023-09-30 | -$141.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $0.00 10-Q · filed 2024-11-06 | ||
| 2023-06-30 | $141.00K 10-Q · filed 2024-08-13 | |||
| 2022-12-31 | $310.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | -$73.00K derived: sum of 2 quarters · filed 2024-03-13 | $263.00K derived: sum of 3 quarters · filed 2024-03-13 | $527.00K 10-K · filed 2024-03-13 |
| 2022-09-30 | -$383.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$47.00K derived: sum of 2 quarters · filed 2023-11-08 | $217.00K 10-Q · filed 2023-11-08 | -$24.00K derived: sum of 4 quarters · filed 2024-03-13 |
| 2022-06-30 | $336.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $600.00K 10-Q · filed 2023-08-14 | $359.00K derived: sum of 3 quarters · filed 2024-03-13 | $657.00K derived: sum of 4 quarters · filed 2024-03-13 |
| 2022-03-31 | $264.00K 10-Q · filed 2023-05-11 | $23.00K derived: sum of 2 quarters · filed 2024-03-13 | $321.00K derived: sum of 3 quarters · filed 2024-03-13 | $358.00K derived: sum of 4 quarters · filed 2024-03-13 |
| 2021-12-31 | -$241.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $57.00K derived: sum of 2 quarters · filed 2024-03-13 | $94.00K derived: sum of 3 quarters · filed 2024-03-13 | $104.00K 10-K · filed 2024-03-13 |
| 2021-09-30 | $298.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $335.00K derived: sum of 2 quarters · filed 2022-11-10 | $345.00K 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $37.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $47.00K 10-Q · filed 2022-08-11 | ||
| 2021-03-31 | $10.00K 10-Q · filed 2022-04-27 | |||
| 2020-12-31 | $20.00K 10-K · filed 2023-03-23 | |||
| 2020-06-30 | -$28.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $27.00K 10-Q · filed 2021-08-16 | $466.00K derived: sum of 3 quarters · filed 2022-03-14 | $122.00K derived: sum of 4 quarters · filed 2022-03-14 |
| 2020-03-31 | $55.00K 10-Q · filed 2021-05-14 | $494.00K derived: sum of 2 quarters · filed 2022-03-14 | $150.00K derived: sum of 3 quarters · filed 2022-03-14 | -$498.00K derived: sum of 4 quarters · filed 2022-03-14 |
| 2019-12-31 | $439.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | $95.00K derived: sum of 2 quarters · filed 2022-03-14 | -$553.00K derived: sum of 3 quarters · filed 2022-03-14 | $490.00K 10-K · filed 2022-03-14 |
| 2019-09-30 | -$344.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$992.00K derived: sum of 2 quarters · filed 2020-11-05 | $51.00K 10-Q · filed 2020-11-05 | $490.00K derived: sum of 4 quarters · filed 2021-03-15 |
| 2019-06-30 | -$648.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $395.00K 10-Q · filed 2020-08-06 | $834.00K derived: sum of 3 quarters · filed 2021-03-15 | $632.00K derived: sum of 4 quarters · filed 2021-03-15 |
| 2019-03-31 | $1.04M 10-Q · filed 2020-05-07 | $1.48M derived: sum of 2 quarters · filed 2021-03-15 | $1.28M derived: sum of 3 quarters · filed 2021-03-15 | $516.00K derived: sum of 4 quarters · filed 2021-03-15 |
| 2018-12-31 | $439.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $237.00K derived: sum of 2 quarters · filed 2021-03-15 | -$527.00K derived: sum of 3 quarters · filed 2021-03-15 | $952.00K 10-K · filed 2021-03-15 |
| 2018-09-30 | -$202.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$966.00K derived: sum of 2 quarters · filed 2019-11-12 | $513.00K 10-Q · filed 2019-11-12 | $567.00K derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-06-30 | -$764.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $715.00K 10-Q · filed 2019-08-14 | $769.00K derived: sum of 3 quarters · filed 2020-03-12 | $661.00K derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-03-31 | $1.48M 10-Q · filed 2019-05-13 | $1.53M derived: sum of 2 quarters · filed 2020-03-12 | $1.43M derived: sum of 3 quarters · filed 2020-03-12 | $1.73M derived: sum of 4 quarters · filed 2020-03-12 |
| 2017-12-31 | $54.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | -$54.00K derived: sum of 2 quarters · filed 2020-03-12 | $249.00K derived: sum of 3 quarters · filed 2020-03-12 | $265.00K 10-K · filed 2020-03-12 |
| 2017-09-30 | -$108.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $195.00K derived: sum of 2 quarters · filed 2018-11-13 | $211.00K 10-Q · filed 2018-11-13 | |
| 2017-06-30 | $303.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | $319.00K 10-Q · filed 2018-08-10 | ||
| 2017-03-31 | $16.00K 10-Q · filed 2018-05-10 | |||
| 2016-12-31 | $116.00K 10-K · filed 2019-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |